The change in separation of mADL scores started after 14 days, Pahwa said at a late-breaking session at the American Academy of Neurology (AAN) annual meeting.. Improvements in Clinical Global ...

In TEMPO-1, two fixed doses of tavapadon -- 5 mg and 15 mg -- showed lower combined part II and III scores versus placebo, said Rajesh Pahwa, MD, of the University of Kansas Medical Center in ...

This drug seems to be better than the current D2, D3 agonists,” study investigator Rajesh Pahwa, MD, professor of neurology and director of the Parkinson's Disease and Movement Disorder Center ...

Oral treatments currently used for essential tremor are “often unsatisfactory,” according to Rajesh Pahwa, MD, FAAN, Laverne and Joyce Rider Professor of Neurology at the University of Kansas ...

For the TEMPO-1 trial, Rajesh Pahwa, MD, FAAN, Laverne and Joyce Rider Professor of Neurology at the University of Kansas School of Medicine and director of the Movement Disorder Program at the ...

“The TRANQUIL study represents what could be a shift in how we approach essential tremor treatment, a condition for which new options are sorely needed,” principal investigator Rajesh Pahwa ...

Dr. Rajesh Pahwa, director of the Parkinson's Foundation Center of Excellence at the University of Kansas Medical Center; Tags. Up To Date Podcast Parkinson's Disease disease KU Medical Center ...

Dr. Rajesh Pahwa, Radiologist. Dr. Rajesh Pahwa is a Radiologist practicing in New Delhi, specializing in the field of Radiology. Are you the doctor associated with this profile?

The change in separation of mADL scores started after 14 days, Pahwa said at a late-breaking session at the American Academy of Neurology (AAN) annual meeting.. Improvements in Clinical Global ...